Experience in treating disseminated breast cancer after multimodality therapy

Median survival in patients with disseminated breast cancer (BC) is less than 3 years; moreover, 25-30 and 10% survive > 5 and > 10 years, respectively. Current systemic therapy increases median survival rates by only 3-4 months as compared with patients who do not receive this therapy...

Full description

Bibliographic Details
Main Authors: G. A. Khakimov, N. R. Shayusupov, G. F. Miryusupova
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Opuholi Ženskoj Reproduktivnoj Sistemy
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/208

Similar Items